Topic

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Articles

Matt Ros, EVP, chief strategy and business officer of Epizyme, talks to Pharm Exec about his career in oncology and his role in transforming an epigenetics R&D company into a fully integrated commercial business.


Patients as the North Star

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

Dr. Husseini Manji talks to Pharm Exec about his new role as J&J's Head of Science for Minds and how he hopes to foster new ways to treat dementia and serious mental disorders and provide holistic mental care.

Advancing the Science for Minds: Dr. Husseini Manji, J&J

Angus Grant, Ph.D., Chief Business Executive of BeiGene, talks to Pharm Exec about his role and his vision for the company’s programs in oncology and beyond.

Partnering for the Future: Angus J. Grant, Chief Business Executive, BeiGene 

Anne E. White, president, Lilly Oncology, talks about how the lessons she learned from leading a startup helped her to speed Lilly’s drug development from target identification through successful launch  

Speed and Sensitivity

A glimpse inside the latest turn in Liz Barrett’s influential journey as an oncology executive—this time leaving the confines of big pharma to tackle the innovation void in treating urologic cancers.


Stepping Out in Oncology

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

EXUMA Biotech's Dr. Greg Frost talks about his work making CAR-T cell therapy readily accessible and affordable.

Expanding Access to CAR-T: Dr. Greg Frost

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.

Tackling a ‘Genius Virus’

Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.

Central Focus: Targeting Unmet Need in CNS

Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.

Executive Profiles